These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17392560)

  • 1. Is there a systemic inflammatory response in the acute charcot foot?
    Petrova NL; Moniz C; Elias DA; Buxton-Thomas M; Bates M; Edmonds ME
    Diabetes Care; 2007 Apr; 30(4):997-8. PubMed ID: 17392560
    [No Abstract]   [Full Text] [Related]  

  • 2. Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy.
    Gough A; Abraha H; Li F; Purewal TS; Foster AV; Watkins PJ; Moniz C; Edmonds ME
    Diabet Med; 1997 Jul; 14(7):527-31. PubMed ID: 9223389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-grade systemic inflammation in patients with amyotrophic lateral sclerosis.
    Keizman D; Rogowski O; Berliner S; Ish-Shalom M; Maimon N; Nefussy B; Artamonov I; Drory VE
    Acta Neurol Scand; 2009 Jun; 119(6):383-9. PubMed ID: 18976328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The vertical component of the ground reaction force does not reflect horizontal braking or acceleration per se.
    Savelberg HH; Schaper NC; Meijer K
    Clin Biomech (Bristol, Avon); 2009 Jul; 24(6):527-8. PubMed ID: 19477057
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: The vertical component of the ground reaction force does not reflect horizontal braking or acceleration per se.
    Sacco IC; Akashi PM; Hennig E
    Clin Biomech (Bristol, Avon); 2009 Aug; 24(7):595. PubMed ID: 19560240
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone mineral density and markers of bone turnover and inflammation in diabetes patients with or without a Charcot foot: An 8.5-year prospective case-control study.
    Jansen RB; Christensen TM; Bülow J; Rørdam L; Holstein PE; Jørgensen NR; Svendsen OL
    J Diabetes Complications; 2018 Feb; 32(2):164-170. PubMed ID: 29196119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum C3 is a stronger inflammatory marker of insulin resistance than C-reactive protein, leukocyte count, and erythrocyte sedimentation rate: comparison study in an elderly population.
    Muscari A; Antonelli S; Bianchi G; Cavrini G; Dapporto S; Ligabue A; Ludovico C; Magalotti D; Poggiopollini G; Zoli M;
    Diabetes Care; 2007 Sep; 30(9):2362-8. PubMed ID: 17595349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvascular and C-fiber function in diabetic charcot neuroarthropathy and diabetic peripheral neuropathy.
    Baker N; Green A; Krishnan S; Rayman G
    Diabetes Care; 2007 Dec; 30(12):3077-9. PubMed ID: 17804679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Charcot foot: a clinical challenge.
    Stefansky SA; Rosenblum BI
    Int J Low Extrem Wounds; 2005 Sep; 4(3):183-7. PubMed ID: 16100099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of C-reactive protein response to other biochemical and hematologic values in blood of rhesus monkey (Macaca mulatta).
    Palumbo NE; Perri SF; Yamada K; Hokama Y
    Am J Vet Res; 1972 Sep; 33(9):1895-900. PubMed ID: 5053171
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship between serum vitamin D and inflammatory markers in the general population: comment on the article by Patel et al.
    Lippi G; Montagnana M; Targher G; Guidi GC
    Arthritis Rheum; 2008 Mar; 58(3):913-4. PubMed ID: 18311799
    [No Abstract]   [Full Text] [Related]  

  • 12. Alterations of peripheral leukocyte count, erythrocyte sedimentation rate, and C-reactive protein in febrile urinary tract infection.
    Naseri M
    Iran J Kidney Dis; 2008 Jul; 2(3):137-42. PubMed ID: 19377227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raised inflammatory markers.
    Watson J; Round A; Hamilton W
    BMJ; 2012 Feb; 344():e454. PubMed ID: 22306478
    [No Abstract]   [Full Text] [Related]  

  • 14. Charcot foot in diabetes: farewell to the neurotrophic theory.
    Chantelau E; Onvlee GJ
    Horm Metab Res; 2006 Jun; 38(6):361-7. PubMed ID: 16823717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Charcot foot.
    Jeffcoate W; Lima J; Nobrega L
    Diabet Med; 2000 Apr; 17(4):253-8. PubMed ID: 10821290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The value of the C-reactive protein reaction in comparison with leukocyte and temperature reactions, as well as erythrocyte sedimentation rate in inflammatory diseases of the female genitalia].
    Ivanova Kh
    Akush Ginekol (Sofiia); 1972; 11(3):237-42. PubMed ID: 4651497
    [No Abstract]   [Full Text] [Related]  

  • 17. Range and determinants of white blood cell count in a large survey of Israelis without inflammation.
    Steinvil A; Berliner S; Herishanu Y; Paran Y; Justo D; Cohen M; Shapira I; Rogowski O
    Isr Med Assoc J; 2009 Jun; 11(6):363-6. PubMed ID: 19697588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the usefulness of inflammation-sensitive biomarkers to reveal potential sex differences in relation to low-grade inflammation in individuals with the metabolic syndrome.
    Rogowski O; Shapira I; Berliner S
    Metabolism; 2008 Sep; 57(9):1221-6. PubMed ID: 18702947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of diabetic neuropathy and previous foot ulceration in EMG and ground reaction forces during gait.
    Akashi PM; Sacco IC; Watari R; Hennig E
    Clin Biomech (Bristol, Avon); 2008 Jun; 23(5):584-92. PubMed ID: 18178296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating deoxyribonucleic acid--synthesizing mononuclear leukocytes. I. Increased numbers of proliferating mononuclear leukocytes in inflammatory disease.
    Horwitz DA; Stastny P; Ziff M
    J Lab Clin Med; 1970 Sep; 76(3):391-402. PubMed ID: 5458330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.